Posts

Showing posts with the label Chimeric antigen receptor T cells

CAR T cell Therapy Is an Advanced Form of Treatment That Is Practiced Worldwide to Help Patients Suffering from Chronic Diseases Such As Cancer

Image
  CAR T cell therapy is the most commonly used form of complementary immunosuppression today in regions such as UK, US, and Italy, and many people are aware of it through the publicity and marketing efforts of global pharmaceutical companies. Chimeric antigen receptor T cells (CAR T cell) are genetically engineered in a lab to generate a synthetic T cell receptor for application in immunotherapy. Many patients are now using this treatment for their chronic illnesses such as chronic hepatitis, cancer, infectious mononucleosis, Crohn's disease, etc. When cancerous cells invade the body, they secrete a protein called interferon-gamma, which can damage healthy cells. This causes the healthy cells to secrete antibodies called macrophages, which chase the interferon-gamma away. This is how the immune system reacts to cancer and results in remission of the illness. The CAR T cells are introduced into the patient's body at this time, and once they start to recognize the cancerous cel...